These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21466446)

  • 1. Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.
    Montana MC; Gereau RW
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1681-8. PubMed ID: 21466446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.
    Palazzo E; Marabese I; de Novellis V; Rossi F; Maione S
    Eur J Neurosci; 2014 Feb; 39(3):444-54. PubMed ID: 24494684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation.
    Mazzitelli M; Palazzo E; Maione S; Neugebauer V
    Front Mol Neurosci; 2018; 11():383. PubMed ID: 30356691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic receptors for glutamate and GABA in pain.
    Goudet C; Magnaghi V; Landry M; Nagy F; Gereau RW; Pin JP
    Brain Res Rev; 2009 Apr; 60(1):43-56. PubMed ID: 19146876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociception modulation by supraspinal group III metabotropic glutamate receptors.
    Palazzo E; Marabese I; Luongo L; Guida F; de Novellis V; Maione S
    J Neurochem; 2017 May; 141(4):507-519. PubMed ID: 27363363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutamatergic system as a target for neuropathic pain relief.
    Osikowicz M; Mika J; Przewlocka B
    Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics.
    Varney MA; Gereau RW
    Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):283-96. PubMed ID: 12769620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptors and neurodegenerative diseases.
    Ribeiro FM; Vieira LB; Pires RG; Olmo RP; Ferguson SS
    Pharmacol Res; 2017 Jan; 115():179-191. PubMed ID: 27872019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
    Chiechio S
    Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
    Alexander GM; Godwin DW
    Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptors as drug targets.
    Récasens M; Guiramand J; Aimar R; Abdulkarim A; Barbanel G
    Curr Drug Targets; 2007 May; 8(5):651-81. PubMed ID: 17504108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic receptors as targets for drugs of potential use in the treatment of neuropathic pain.
    Chiechio S; Copani A; Melchiorri D; Canudas AM; Storto M; Calvani M; Nicolai R; Nicoletti F
    J Endocrinol Invest; 2004; 27(6 Suppl):171-6. PubMed ID: 15481819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of group III metabotropic glutamate receptor ligands in pain.
    Acher F; Goudet C
    Curr Opin Pharmacol; 2015 Feb; 20():64-72. PubMed ID: 25498980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells.
    Neugebauer V; Chen PS; Willis WD
    J Neurophysiol; 2000 Dec; 84(6):2998-3009. PubMed ID: 11110827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.
    Mazzitelli M; Presto P; Antenucci N; Meltan S; Neugebauer V
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of neuronal excitability and epileptic activities by group II metabotropic glutamate receptors in the medial entorhinal cortex.
    Zhang H; Cilz NI; Yang C; Hu B; Dong H; Lei S
    Hippocampus; 2015 Nov; 25(11):1299-313. PubMed ID: 25740117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor ligands as potential therapeutics for addiction.
    Olive MF
    Curr Drug Abuse Rev; 2009 Jan; 2(1):83-98. PubMed ID: 19630739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraspinal metabotropic glutamate receptor subtype 8: a switch to turn off pain.
    Palazzo E; de Novellis V; Rossi F; Maione S
    Amino Acids; 2014 Jun; 46(6):1441-8. PubMed ID: 24623118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group I metabotropic glutamate receptor plasticity after peripheral inflammation alters nociceptive transmission in the dorsal of the spinal cord in adult rats.
    Radwani H; Roca-Lapirot O; Aby F; Lopez-Gonzalez MJ; Benazzouz R; Errami M; Favereaux A; Landry M; Fossat P
    Mol Pain; 2017; 13():1744806917737934. PubMed ID: 29020860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.